185 related articles for article (PubMed ID: 25397683)
1. Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression.
Hasselbalch HC; Thomassen M; Riley CH; Kjær L; Larsen TS; Jensen MK; Bjerrum OW; Kruse TA; Skov V
PLoS One; 2014; 9(11):e112786. PubMed ID: 25397683
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms.
Skov V; Thomassen M; Kjær L; Ellervik C; Larsen MK; Knudsen TA; Kruse TA; Hasselbalch HC
PLoS One; 2022; 17(6):e0270669. PubMed ID: 35771847
[TBL] [Abstract][Full Text] [Related]
3. Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasms.
Skov V; Thomassen M; Kjaer L; Larsen MK; Knudsen TA; Ellervik C; Kruse TA; Hasselbalch HC
Eur J Haematol; 2023 Nov; 111(5):805-814. PubMed ID: 37640394
[TBL] [Abstract][Full Text] [Related]
4. Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis.
Skov V; Larsen TS; Thomassen M; Riley CH; Jensen MK; Bjerrum OW; Kruse TA; Hasselbalch HC
Eur J Haematol; 2011 Jul; 87(1):54-60. PubMed ID: 21447007
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
Hasselbalch HC
Leuk Res; 2013 Feb; 37(2):214-20. PubMed ID: 23174192
[TBL] [Abstract][Full Text] [Related]
6. Correction: Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of nrf2 for genomic instability and disease progression.
The
PLoS One; 2015; 10(2):e0118049. PubMed ID: 25643029
[TBL] [Abstract][Full Text] [Related]
7. Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway.
Čokić VP; Mossuz P; Han J; Socoro N; Beleslin-Čokić BB; Mitrović O; Subotički T; Diklić M; Leković D; Gotić M; Puri RK; Noguchi CT; Schechter AN
PLoS One; 2015; 10(8):e0135463. PubMed ID: 26275051
[TBL] [Abstract][Full Text] [Related]
8. Increased protein oxidation and decreased expression of nuclear factor E2-related factor 2 protein in skin tissue of patients with diabetes.
Lee YJ; Kwon SB; An JM; Kim CH; Lee SH; Choi CY; Nam DH; Park JW; Nam HS; Lee SH; Lee MW; Cho MK
Clin Exp Dermatol; 2015 Mar; 40(2):192-200. PubMed ID: 25557240
[TBL] [Abstract][Full Text] [Related]
9. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.
Kim HJ; Vaziri ND
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347
[TBL] [Abstract][Full Text] [Related]
10. The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.
Tadmor T; Bejar J; Attias D; Mischenko E; Sabo E; Neufeld G; Vadasz Z
Am J Hematol; 2013 May; 88(5):355-8. PubMed ID: 23494965
[TBL] [Abstract][Full Text] [Related]
11. JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms.
Payzin KB; Savasoglu K; Alacacioglu I; Ozdemirkiran F; Mutlu BB; Bener S; Calli AO; Kucukzeybek BB; Aksun S
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):525-33. PubMed ID: 24811089
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms.
Čokić VP; Mitrović-Ajtić O; Beleslin-Čokić BB; Marković D; Buač M; Diklić M; Kraguljac-Kurtović N; Damjanović S; Milenković P; Gotić M; Raj PK
Mediators Inflamm; 2015; 2015():453020. PubMed ID: 26491227
[TBL] [Abstract][Full Text] [Related]
13. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.
Mesa R; Miller CB; Thyne M; Mangan J; Goldberger S; Fazal S; Ma X; Wilson W; Paranagama DC; Dubinski DG; Boyle J; Mascarenhas JO
BMC Cancer; 2016 Feb; 16():167. PubMed ID: 26922064
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: identification of deregulated genes of significance for inflammation and immune surveillance.
Skov V; Larsen TS; Thomassen M; Riley CH; Jensen MK; Bjerrum OW; Kruse TA; Hasselbalch HC
Leuk Res; 2012 Nov; 36(11):1387-92. PubMed ID: 22877729
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis.
Skov V; Thomassen M; Riley CH; Jensen MK; Bjerrum OW; Kruse TA; Hasselbalch HC; Larsen TS
Exp Hematol; 2012 Sep; 40(9):771-780.e19. PubMed ID: 22659388
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferative neoplasms.
Harada-Shirado K; Ikeda K; Ogawa K; Ohkawara H; Kimura H; Kai T; Noji H; Morishita S; Komatsu N; Takeishi Y
Br J Haematol; 2015 Feb; 168(3):338-49. PubMed ID: 25236537
[TBL] [Abstract][Full Text] [Related]
17. BCR-ABL negative myeloproliferative neoplasia: a review of involved molecular mechanisms.
Koopmans SM; Schouten HC; van Marion AM
Histol Histopathol; 2015 Feb; 30(2):151-61. PubMed ID: 25196073
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidant Chemicals for Cancer Prevention in Humans.
Prasad KN
J Am Coll Nutr; 2016; 35(2):175-84. PubMed ID: 26151600
[TBL] [Abstract][Full Text] [Related]
19. Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR-ABL-Negative Myeloproliferative Neoplasm.
Allegra A; Pioggia G; Tonacci A; Casciaro M; Musolino C; Gangemi S
Antioxidants (Basel); 2020 Oct; 9(11):. PubMed ID: 33114087
[TBL] [Abstract][Full Text] [Related]
20. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells.
Huang K; Chen C; Hao J; Huang J; Wang S; Liu P; Huang H
Mol Cell Endocrinol; 2015 Jan; 399():178-89. PubMed ID: 25192797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
